Company profile

MindMaze Therapeutics Holding SA insider transactions

MONDCH

Management transactions

1

Shareholding disclosures

188

First disclosure

01.09.2009

Last disclosure

19.09.2026

Company summary

Over 90 days: 0 purchases (CHF 0.00) and 1 sales (CHF 10 k). Disclosed flows are net selling.

Latest purchase
—

—

Net flow 90 d
CHF -10’140

Buys − sales

Top shareholder
59.322%

MindMaze Therapeutics Holding SA

Latest priced trade (14.09.2026): CHF 10 k, 0.4× the median of 17 earlier same-direction trades over one year. Compare with its own history, not another company’s.

This page brings together all MindMaze Therapeutics Holding SA (MONDCH) insider transactions: 1 management transactions and 188 significant shareholding disclosures published by SIX Exchange Regulation, from 01.09.2009 to 19.09.2026.

Detailed context

SIX Exchange Regulation has published 1 management transactions and 188 significant shareholding disclosures for MindMaze Therapeutics Holding SA, providing data for the monitoring of insider transactions. Within the last 90 days, there were 0 purchases for CHF 0 and 1 sales totaling CHF 10'140, with the latest management transaction dated 2026-09-14. The largest declared shareholders by voting rights include RELIEF THERAPEUTICS Holding SA at 76.56%, MindMaze Therapeutics Holding SA and Relief Therapeutics International SA both at 59.322%, and Christopher Brown at 49.889%.

Insider barometer

90 days

1 transactions

CHF -10’140

Net selling

Declared purchases 0%Declared sales 100%
Net flowNet selling

Declared purchases

CHF 0.00

Declared sales

CHF 10’140

Latest transaction

14.09.2026

Largest purchase

CHF 405.93

Largest sale

CHF 551’890

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Follow MindMaze Therapeutics Holding SA’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

MindMaze Therapeutics Holding SA insider transactions

SaleManagement transactions

MindMaze Therapeutics Holding SA

Non-executive member of the board of directors · Registered shares

CHF 10’14060’000 × CHF 0.1714.09.2026
SaleManagement transactions

MindMaze Therapeutics Holding SA

Non-executive member of the board of directors · Registered shares

CHF 61’60649’000 × CHF 1.2619.01.2026
SaleManagement transactions

MindMaze Therapeutics Holding SA

Non-executive member of the board of directors · Registered shares

CHF 158’417100’000 × CHF 1.5805.01.2026
SaleManagement transactions

MindMaze Therapeutics Holding SA

Non-executive member of the board of directors · Registered shares

CHF 146’25065’000 × CHF 2.2523.12.2025
SaleManagement transactions

MindMaze Therapeutics Holding SA

Non-executive member of the board of directors · Registered shares

CHF 152’50469’000 × CHF 2.2122.12.2025
SaleManagement transactions

MindMaze Therapeutics Holding SA

Non-executive member of the board of directors · Registered shares

CHF 99’33937’000 × CHF 2.6819.12.2025
SaleManagement transactions

MindMaze Therapeutics Holding SA

Non-executive member of the board of directors · Registered shares

CHF 231’017140’000 × CHF 1.6516.12.2025
SaleManagement transactions

MindMaze Therapeutics Holding SA

Non-executive member of the board of directors · Registered shares

CHF 54’77052’162 × CHF 1.0516.12.2025
SaleManagement transactions

MindMaze Therapeutics Holding SA

Non-executive member of the board of directors · Registered shares

CHF 412’000281’968 × CHF 1.4615.12.2025
SaleManagement transactions

MindMaze Therapeutics Holding SA

Executive member of the board of directors / senior management · Registered shares

CHF 1’770600 × CHF 2.9506.11.2025

Latest shareholding disclosures